SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for NUPLAZID® (pimavanserin) for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). The CRL indicated that the … [Read more…]

 An innovative and cost-effective alternative to traditional staffing firms, the flipMD Hire platform allows healthcare companies to now recruit for full-time and temporary physician positions, in addition to consulting opportunities PHILADELPHIA–(BUSINESS WIRE)–Please replace the release dated August 3, 2022 with the following corrected version due to multiple revisions. The updated release reads: FLIPMD LAUNCHES NEW … [Read more…]

AHF thanks U.S. President Joe Biden for proclaiming a national state of emergency on monkeypox earlier today; urges federal government to immediately allocate money, staff and resources nationally LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) commended President Joseph Biden for proclaiming a national state of emergency on monkeypox earlier today. The move comes as more than … [Read more…]

RICHMOND, Va.–(BUSINESS WIRE)–McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver sponsor of the National Association of Community Health Center (NACHC) National Health Center Week 2022 (NHCW) on Aug. 7-13. The theme of NHCW 2022 is “Community Health Centers: The Chemistry for Strong Communities.” As a strong supporter of the nation’s … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its second quarter 2022 financial results for the period ended June 30, 2022. “We are pleased to report continued reductions in operating expenses as we remain focused on conserving cash to ensure that we have sufficient financial resources to capture future potential … [Read more…]

Granted FDA Fast Track Designation for APC Clinical Candidate Published Comprehensive Preclinical Research on SQZ® TAC Platform in Frontiers in Immunology Presented First SQZ® Point-of-Care (POC) Manufacturing System Performance Data; Initial Clinical Use Planned for SQZ® TAC Celiac Disease Program with IND Submission Expected in First Half 2023 Strengthened Leadership with Experienced CMO and CFO … [Read more…]

FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2022 financial results after the market closes on Thursday, August 11, 2022 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as … [Read more…]

EXETER, N.H.–(BUSINESS WIRE)–Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that its management team will be participating in the Canaccord Genuity … [Read more…]

CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors approved a 5% increase to the company’s quarterly cash dividend to $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2022, to stockholders of record … [Read more…]

Second Quarter 2022 is Highest Product Revenue in Company History Total Revenue of $47.6 Million Grew 26% YoY in the Second Quarter Product Revenue of $41.0 Million Grew 30% YoY in the Second Quarter Reiterating Full-Year 2022 Product Revenue Guidance Range of $160-165 Million CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) today announced financial results for … [Read more…]